RLFTF
Price:
$7.28
Market Cap:
$78.68M
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lu...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
RLFTF
According to Relief Therapeutics Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 67.96M. This represents a change of 551.80% compared to the average of 10.43M of the last 4 quarters.
The mean historical Enterprise Value of Relief Therapeutics Holding AG over the last ten years is 185.02M. The current 67.96M Enterprise Value has changed 3.57% with respect to the historical average. Over the past ten years (40 quarters), RLFTF's Enterprise Value was at its highest in in the September 2020 quarter at 1.27B. The Enterprise Value was at its lowest in in the December 2014 quarter at -1105033.00.
Average
185.02M
Median
157.63M
Minimum
13.77M
Maximum
625.33M
Discovering the peaks and valleys of Relief Therapeutics Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 173.71%
Maximum Annual Enterprise Value = 625.33M
Minimum Annual Increase = -86.00%
Minimum Annual Enterprise Value = 13.77M
Year | Enterprise Value | Change |
---|---|---|
2023 | 13.77M | -86.00% |
2022 | 98.31M | -42.40% |
2021 | 170.68M | -72.71% |
2020 | 625.33M | 173.71% |
2019 | 228.46M | -0.68% |
2018 | 230.03M | 5.79% |
2017 | 217.44M | 50.39% |
2016 | 144.58M | 106.99% |
2015 | 69.85M | 35.05% |
2014 | 51.72M | 110.44% |
The current Enterprise Value of Relief Therapeutics Holding AG (RLFTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
94.25M
5-year avg
227.31M
10-year avg
185.02M
Relief Therapeutics Holding AG’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relief Therapeutics Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Relief Therapeutics Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Relief Therapeutics Holding AG's Enterprise Value?
What is the highest Enterprise Value for Relief Therapeutics Holding AG (RLFTF)?
What is the 3-year average Enterprise Value for Relief Therapeutics Holding AG (RLFTF)?
What is the 5-year average Enterprise Value for Relief Therapeutics Holding AG (RLFTF)?
How does the current Enterprise Value for Relief Therapeutics Holding AG (RLFTF) compare to its historical average?